Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | MET | P08581 | 1/20 | 0.42 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HTR6 | P50406 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | PARL | Q9H300 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1976805 | 0.81 | CA1 (0.50) | SLC9A1ALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL5396539 | 0.80 | GRM4 (0.44) | ALDH1A1HTR6MEN1KMT2ALMNA | |
| SCHEMBL3734126 | 0.78 | PARL (0.47) | ALDH1A1MEN1KMT2ALMNAHPGD | |
| SCHEMBL4254051 | 0.74 | POLB (0.54) | CYP2C19METSLC9A1ALDH1A1HTR6 | |
| SCHEMBL8712666 | 0.73 | NOTUM (0.42) | CYP2C19SLC9A1ALDH1A1HTR6MEN1 | |
| SCHEMBL29414534 | 0.73 | CYP19A1 (0.47) | CYP2C19ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL7368521 | 0.72 | ALDH1A1 (0.40) | CYP2C19METSLC9A1ALDH1A1HTR6 | |
| SCHEMBL29589411 | 0.69 | PARL (0.46) | ALDH1A1HTR6MEN1KMT2AHPGD | |
| SCHEMBL2762763 | 0.68 | ALDH1A1 (0.66) | ALDH1A1HTR6KMT2ALMNATSHR | |
| SCHEMBL4252110 | 0.68 | ALDH1A1 (0.47) | CYP2C19METSLC9A1ALDH1A1HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129031-A1 | 1,2,3-TRIAZOLE CARBONYL SULFONYLAMIDE COMPOUNDS AND USE THEREOF | PI INDUSTRIES LTD (IN) | 2025-04-24 | — | — | US | disclosed |
| US-6673747-B2 | FOR CONTROLLING OF UNDESIRED PLANT GROWTH IN CROPS OF CULTIVATED PLANTS | SYNGENTA PARTICIPATIONS AG (CH) | 2004-01-06 | — | — | US | disclosed |
| US-20020193253-A1 | Herbicidal composition | KRUGER CHRISTIAN (DE) | 2002-12-19 | — | — | US | disclosed |
| US-20020045549-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-04-18 | — | — | US | disclosed |
| EP-1126758-A1 | HERBICIDAL COMPOSITION | Syngenta Participations AG (CH) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000025586-A1 | HERBICIDAL COMPOSITION | SYNGENTA PARTICIPATIONS AG (CH) | 2000-05-11 | — | — | WO | disclosed |
| EP-0605230-A1 | Hexanhydronaphthalene ester derivatives, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1994-07-06 | — | — | EP | disclosed |
| US-4474947-A | Benzazolides and their employment in phosphate ester oligonucleotide synthesis processes | BIOSEARCH (US) | 1984-10-02 | — | — | US | disclosed |
| US-4426517-A | Process for de-cyanoethylating blocked nucleotides | ELI LILLY AND COMPANY (US) | 1984-01-17 | — | — | US | disclosed |
| US-4419509-A | Process for de-cyanoethylating blocked nucleotides | ELI LILLY AND COMPANY (US) | 1983-12-06 | — | — | US | disclosed |
| US-4417046-A | Process for isolating oligonucleotide product from a coupling reaction mixture | ELI LILLY AND COMPANY (US) | 1983-11-22 | — | — | US | disclosed |
| EP-0075392-A1 | Process for de-cyanoethylating blocked nucleotides | ELI LILLY AND COMPANY (US) | 1983-03-30 | — | — | EP | disclosed |
| EP-0002322-A2 | Improved Triester process for the synthesis of oligonucleotides | GENENTECH, INC. (US) | 1979-06-13 | — | — | EP | disclosed |
| US-3963731-A | TREATMENT OF GOUT AND HYPERURICEMIA | MERCK & CO., INC. (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193253-A1 | Herbicidal composition | DDT, DPP4, DPP7 | CYP2C19 695/4885MET 478/4885SLC9A1 1979/4885 |
| US-20250129031-A1 | 1,2,3-TRIAZOLE CARBONYL SULFONYLAMIDE COMPOUNDS AND USE THEREOF | GLP1R, CBR3, CBR1 | CYP2C19 1085/4885MET 4207/4885SLC9A1 725/4885 |
| US-20020045549-A1 | Herbicidal composition | DDT, DPP4, DPP7 | CYP2C19 695/4885MET 478/4885SLC9A1 1979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.